syndrome	score	normalized_score
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	2.00378788	100.0
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.5	74.85822301709901
SACCHAROPINURIA	1.325	66.12476366510411
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	1.31303957	65.52787264089051
DIBASIC AMINO ACIDURIA I	1.291666	64.46121432773613
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	1.111111	55.45053002316792
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	1.09757577	54.77504784588276
DICARBOXYLICAMINO ACIDURIA	1.0136986	50.58911724728068
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	1.00704225	50.25692889209411
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	1.00347222	50.07876482414895
BNAR SYNDROME	1.0	49.905482011399336
PULMONARY ARTERIOVENOUS MALFORMATION	1.0	49.905482011399336
TEMPI SYNDROME	1.0	49.905482011399336
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	1.0	49.905482011399336
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	49.905482011399336
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.833333	41.58788504100544
LYSINURIC PROTEIN INTOLERANCE	0.8063719	40.2423783499479
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.7402210400000001	36.94108779617931
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.7	34.93383740797953
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.67825389	33.848587306556624
GLUTARIC ACIDEMIA I; GA1	0.67712117	33.79205836897267
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.6397059	31.92483128503602
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.625	31.19092625712458
HAWKINSINURIA	0.583333	29.111514538155603
HAWKINSINURIA	0.583333	29.111514538155603
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.52636367	26.26843266463913
ARGININEMIA	0.5147059	25.686646033611105
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.51370892	25.636891266155377
MEVALONIC ACIDURIA; MEVA	0.51209291	25.55624350817014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.50666667	25.285444385460597
HARTNUP DISORDER	0.5	24.952741005699668
TRYPTOPHANURIA WITH DWARFISM	0.5	24.952741005699668
HARTNUP DISEASE	0.5	24.952741005699668
UROCANIC ACIDURIA	0.5	24.952741005699668
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.5	24.952741005699668
KETOADIPICACIDURIA	0.5	24.952741005699668
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	24.952741005699668
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	24.952741005699668
THREONINEMIA	0.5	24.952741005699668
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.5	24.952741005699668
HYPERTRYPTOPHANEMIA; HYPTRP	0.5	24.952741005699668
HSD10 DISEASE	0.5	24.952741005699668
%109160 AZOTEMIA, FAMILIAL	0.5	24.952741005699668
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.5	24.952741005699668
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.44049047	21.98288922677784
HYPERPROLINEMIA, TYPE II	0.4337661	21.647306300704845
IMINOGLYCINURIA	0.4337661	21.647306300704845
HYPERPROLINEMIA, TYPE I	0.4337661	21.647306300704845
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.4199345	20.957033635715973
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.4199345	20.957033635715973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33712088	16.824180012507114
PENTOSURIA	0.333333	16.635144035305775
ADRENOCORTICAL CARCINOMA	0.333333	16.635144035305775
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.635144035305775
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.333333	16.635144035305775
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.33137259999999996	16.537309328370625
DIAMINOPENTANURIA	0.325	16.219281653704783
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.3235294	16.145890651858817
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.32252210000000003	16.09562085982874
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.30212117	15.077502614697918
CONGENITAL ENTEROVIRUS INFECTION	0.29351746	14.648130320061622
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.28740755	14.343212316465353
TYROSINE TRANSAMINASE DEFICIENCY	0.2611111	13.03087530402669
MUSCULAR DYSTROPHY, CARDIAC TYPE	0.25347222	12.649653315599455
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25	12.476370502849834
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	12.476370502849834
HYPERTRICHOSIS CUBITI	0.25	12.476370502849834
CYSTATHIONINURIA	0.25	12.476370502849834
TUBERCULOSIS	0.25	12.476370502849834
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.25	12.476370502849834
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	12.476370502849834
CYSTATHIONINURIA	0.25	12.476370502849834
CARNOSINEMIA	0.25	12.476370502849834
HOMOCARNOSINOSIS	0.25	12.476370502849834
CITRULLINEMIA TYPE II	0.25	12.476370502849834
BIOTINIDASE DEFICIENCY	0.25	12.476370502849834
CARNOSINASE DEFICIENCY	0.25	12.476370502849834
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.25	12.476370502849834
PLACENTAL INSUFFICIENCY	0.25	12.476370502849834
KAPOSI SARCOMA	0.25	12.476370502849834
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.25	12.476370502849834
WEST SYNDROME	0.25	12.476370502849834
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.24545450000000002	12.249525134367017
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.23544809	11.75015042011333
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.22174815	11.06644831088608
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.216667	10.812871070963858
2P21 MICRODELETION SYNDROME	0.21370892000000002	10.66524666273558
HYPOTONIA-CYSTINURIA SYNDROME	0.20704225	10.332543282974644
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.20666667000000002	10.313799782040803
HYPOTONIA-CYSTINURIA SYNDROME	0.2	9.981096402279867
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.2	9.981096402279867
HYPERPROLINEMIA TYPE 1	0.2	9.981096402279867
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	9.981096402279867
HISTIDINEMIA	0.2	9.981096402279867
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.2	9.981096402279867
HISTIDINEMIA	0.2	9.981096402279867
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.2	9.981096402279867
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.981096402279867
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.2	9.981096402279867
SHOX-RELATED SHORT STATURE	0.2	9.981096402279867
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	9.981096402279867
METHYLMALONIC ACIDURIA, CBLB TYPE	0.1814839	9.057041506808595
METHYLMALONIC ACIDURIA, CBLA TYPE	0.1814839	9.057041506808595
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.18036560000000001	9.001232206275247
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.17370925	8.66904385108867
ETHYLMALONIC ENCEPHALOPATHY	0.17370925	8.66904385108867
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.17045488	8.506632947595232
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.1699345	8.48066313286614
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.1699345	8.48066313286614
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.1699345	8.48066313286614
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.166667	8.317596970393893
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.166667	8.317596970393893
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.166667	8.317596970393893
VERRUCOUS HEMANGIOMA	0.166667	8.317596970393893
CUTANEOUS NEUROENDOCRINE CARCINOMA	0.166667	8.317596970393893
ACRODERMATITIS ENTEROPATHICA	0.166667	8.317596970393893
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.166667	8.317596970393893
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1	0.166667	8.317596970393893
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.166667	8.317596970393893
AGEL AMYLOIDOSIS	0.166667	8.317596970393893
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.166667	8.317596970393893
GITELMAN SYNDROME	0.15000000000000002	7.4858223017099
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.14855374	7.413645999296092
CAMPTODACTYLY-TAURINURIA SYNDROME	0.14285699999999998	7.129347443702473
FAMILIAL EXPANSILE OSTEOLYSIS	0.14285699999999998	7.129347443702473
CAMPTODACTYLY 1; CAMPD1	0.14285699999999998	7.129347443702473
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.14285699999999998	7.129347443702473
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.14285699999999998	7.129347443702473
HYPERTAURINURIC CARDIOMYOPATHY	0.14285699999999998	7.129347443702473
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.14285699999999998	7.129347443702473
BRUCK SYNDROME 2	0.14285699999999998	7.129347443702473
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.14285699999999998	7.129347443702473
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.14285699999999998	7.129347443702473
HYPER-BETA-ALANINEMIA	0.14285699999999998	7.129347443702473
BETA-KETOTHIOLASE DEFICIENCY	0.14211446	7.09229062708973
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.14053601999999998	7.013517818063655
TIGLIC ACIDEMIA	0.1350221	6.7383429826913614
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.13215686999999998	6.59535229846784
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.13151919999999998	6.5635290697536295
HYDROXYLYSINURIA	0.125	6.238185251424917
LYSINE MALABSORPTION SYNDROME	0.125	6.238185251424917
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.12480959999999999	6.228683247649946
PROPIONIC ACIDEMIA	0.11932392	5.954917743089653
BARTH SYNDROME; BTHS	0.1166667	5.822307898179322
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.11575389	5.776753675144497
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.11265725	5.622214363328718
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.11265725	5.622214363328718
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.1121212	5.5954625296965075
SARCOIDOSIS	0.11111099999999999	5.545048011768591
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.11111099999999999	5.545048011768591
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.11111099999999999	5.545048011768591
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.11111099999999999	5.545048011768591
HENNEKAM SYNDROME	0.11111099999999999	5.545048011768591
PRIMARY HYPEROXALURIA	0.11111099999999999	5.545048011768591
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.11111099999999999	5.545048011768591
PRIMARY HYPEROXALURIA TYPE 1	0.11111099999999999	5.545048011768591
LYMPHANGIOLEIOMYOMATOSIS	0.11111099999999999	5.545048011768591
PRIMARY HYPEROXALURIA TYPE 2	0.11111099999999999	5.545048011768591
PRIMARY HYPEROXALURIA TYPE 3	0.11111099999999999	5.545048011768591
LYMPHEDEMA, HEREDITARY, III	0.11111099999999999	5.545048011768591
NEPHROLITHIASIS, CALCIUM OXALATE	0.11111099999999999	5.545048011768591
RADIO-RENAL SYNDROME	0.11111099999999999	5.545048011768591
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.11111099999999999	5.545048011768591
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.11111099999999999	5.545048011768591
FRYNS SYNDROME; FRNS	0.11111099999999999	5.545048011768591
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.10795450000000001	5.387521357799609
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10666667	5.323251580900869
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.105615	5.27076748263394
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.105615	5.27076748263394
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.10461802	5.221012715178216
RABSON-MENDENHALL SYNDROME	0.1	4.990548201139934
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	4.990548201139934
X-LINKED ACROGIGANTISM	0.1	4.990548201139934
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	4.990548201139934
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1	4.990548201139934
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	4.990548201139934
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	4.990548201139934
RIBOFLAVIN DEFICIENCY	0.09757577	4.8695658344834385
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.09704222000000001	4.842938764556258
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0970319	4.842423739981899
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.09438132	4.710145267472124
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.536862454722503
GLYCINE ENCEPHALOPATHY; GCE	0.0909091	4.536862454722503
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.536862454722503
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.0909091	4.536862454722503
GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS	0.0909091	4.536862454722503
GLUCOGLYCINURIA	0.0909091	4.536862454722503
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.08999997000000001	4.49149188386148
PROPIONIC ACIDEMIA	0.08803926999999999	4.393642205281728
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.08803926999999999	4.393642205281728
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.08333330000000001	4.158788504100545
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.08333330000000001	4.158788504100545
CYSTINOSIS, NEPHROPATHIC; CTNS	0.08333330000000001	4.158788504100545
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08333330000000001	4.158788504100545
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.08333330000000001	4.158788504100545
TYROSINEMIA TYPE 1	0.08333330000000001	4.158788504100545
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.08303657	4.143980050423302
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.08137259999999999	4.060938825520792
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.08137259999999999	4.060938825520792
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.08037562	4.011184058065068
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0803653	4.010669033490711
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.08015151000000001	3.9999997404914938
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.07841482	3.913329388937117
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.07734154	3.859766833203922
MAPLE SYRUP URINE DISEASE; MSUD	0.07620892	3.8032428861681704
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.07620892	3.8032428861681704
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.07599432	3.7925331697285243
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.07459291	3.722595128182929
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.07370895	3.6784806783041324
WOLCOTT-RALLISON SYNDROME	0.07333337	3.659737177370291
GLYCEROL KINASE DEFICIENCY; GKD	0.07333337	3.659737177370291
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0725221	3.6192503569789034
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0725221	3.6192503569789034
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.07174815000000001	3.5806260091761812
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.07067487	3.5270634534429863
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.07013892	3.5003166103589765
XP21 MICRODELETION SYNDROME	0.07013892	3.5003166103589765
GLYCOGEN STORAGE DISEASE IXC	0.06954225	3.4705395064072353
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06954225	3.4705395064072353
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.06916667	3.451796005473394
SHORT STATURE DUE TO GHSR DEFICIENCY	0.06916667	3.451796005473394
GLYCOGEN STORAGE DISEASE IXA	0.06916667	3.451796005473394
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.06916667	3.451796005473394
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.06722686	3.3549888524128617
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.06722686	3.3549888524128617
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.06720265	3.3537806406933655
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	3.3270337976093556
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0666667	3.3270337976093556
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	3.3270337976093556
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0666667	3.3270337976093556
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0666667	3.3270337976093556
AMISH LETHAL MICROCEPHALY	0.0666667	3.3270337976093556
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0666667	3.3270337976093556
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.06619535	3.3035108486632825
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0647059	3.229179128481404
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.06370892	3.1794243610256787
GLYCOGEN STORAGE DISEASE 0, LIVER	0.0625	3.1190926257124585
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0625	3.1190926257124585
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.05916342	2.9525789925428634
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0588235	2.9356151210975487
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.9356151210975487
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0588235	2.9356151210975487
VICI SYNDROME; VICIS	0.0588235	2.9356151210975487
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0588235	2.9356151210975487
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.9356151210975487
ACQUIRED METHEMOGLOBINEMIA	0.0588235	2.9356151210975487
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0588235	2.9356151210975487
TRANSCOBALAMIN DEFICIENCY	0.0588235	2.9356151210975487
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0588235	2.9356151210975487
SÉZARY SYNDROME	0.05862069	2.9254937902908167
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05840336	2.9146478318852793
MICROFORM HOLOPROSENCEPHALY	0.05840336	2.9146478318852793
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.05840336	2.9146478318852793
HYDROXYKYNURENINURIA	0.0571769	2.8534407544175786
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.05666667	2.8279774803309023
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.05522876	2.756217888691891
HYPOPLASMINOGENEMIA	0.0545894	2.7243103197130827
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	2.7243103197130827
FOCAL DERMAL HYPOPLASIA	0.0515873	2.574489072166661
PROTEUS SYNDROME	0.0515873	2.574489072166661
ULBRIGHT-HODES SYNDROME	0.05	2.495274100569967
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	2.495274100569967
THYMOMA	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.05	2.495274100569967
STEVENS-JOHNSON SYNDROME	0.05	2.495274100569967
CAUDAL REGRESSION SEQUENCE	0.05	2.495274100569967
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.05	2.495274100569967
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	2.495274100569967
JUVENILE IDIOPATHIC ARTHRITIS	0.05	2.495274100569967
PENILE AGENESIS	0.05	2.495274100569967
FOIX-CHAVANY-MARIE SYNDROME	0.05	2.495274100569967
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.05	2.495274100569967
RHEUMATIC FEVER	0.05	2.495274100569967
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.05	2.495274100569967
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.05	2.495274100569967
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	2.495274100569967
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.05	2.495274100569967
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05	2.495274100569967
ESOPHAGEAL ATRESIA	0.05	2.495274100569967
TOXIC EPIDERMAL NECROLYSIS	0.05	2.495274100569967
FEMORAL-FACIAL SYNDROME	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.05	2.495274100569967
MUCOPOLYSACCHARIDOSIS TYPE 7	0.05	2.495274100569967
LEGIONELLOSIS	0.05	2.495274100569967
FAMILIAL DYSAUTONOMIA	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.05	2.495274100569967
DILATED CARDIOMYOPATHY WITH ATAXIA	0.05	2.495274100569967
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.05	2.495274100569967
HYPOPLASTIC LEFT HEART SYNDROME	0.05	2.495274100569967
X-LINKED IMMUNONEUROLOGIC DISORDER	0.05	2.495274100569967
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.05	2.495274100569967
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.05	2.495274100569967
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	2.495274100569967
FAMILIAL SPONTANEOUS PNEUMOTHORAX	0.05	2.495274100569967
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.05	2.495274100569967
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	2.495274100569967
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.05	2.495274100569967
SENGERS SYNDROME	0.05	2.495274100569967
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.05	2.495274100569967
GIANT CELL ARTERITIS	0.05	2.495274100569967
REACTIVE ARTHRITIS	0.05	2.495274100569967
PELIZAEUS-MERZBACHER DISEASE	0.04840336	2.415593011771286
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.047266180000000005	2.3588414957375634
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04565769	2.278569026977047
TRANSIENT NEONATAL DIABETES MELLITUS	0.0454545	2.268428732087151
RICHARDS-RUNDLE SYNDROME; RRNS	0.0454545	2.268428732087151
PERMANENT NEONATAL DIABETES MELLITUS	0.0454545	2.268428732087151
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0454545	2.268428732087151
RICHARDS-RUNDLE SYNDROME	0.0454545	2.268428732087151
FAMILIAL MULTIPLE NEVI FLAMMEI	0.044334990000000005	2.2125590459205693
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.044334990000000005	2.2125590459205693
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.04411766	2.201713087515032
SILVER-RUSSELL SYNDROME	0.04411766	2.201713087515032
ALKAPTONURIA	0.04378788	2.1852552576573125
VISCERAL STEATOSIS, CONGENITAL	0.04370367	2.1810527170171325
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	2.1698055185362235
LICHTENSTEIN SYNDROME	0.043478300000000004	2.1698055185362235
JUVENILE XANTHOGRANULOMA	0.043478300000000004	2.1698055185362235
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	2.1698055185362235
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	2.1698055185362235
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.1698055185362235
SLC35A2-CDG	0.043478300000000004	2.1698055185362235
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	2.1698055185362235
NEUROFIBROMATOSIS TYPE 1	0.043478300000000004	2.1698055185362235
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	2.1698055185362235
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	2.1698055185362235
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	2.1698055185362235
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	2.1698055185362235
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	2.1698055185362235
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	2.1698055185362235
RHEUMATOID ARTHRITIS	0.043478300000000004	2.1698055185362235
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	2.1698055185362235
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	2.1698055185362235
BLACKFAN-DIAMOND ANEMIA	0.04	1.996219280455973
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.996219280455973
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.996219280455973
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.996219280455973
NON-DISTAL TRISOMY 10Q	0.04	1.996219280455973
3Q13 MICRODELETION SYNDROME	0.04	1.996219280455973
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.996219280455973
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.996219280455973
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	1.996219280455973
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	1.996219280455973
MECKEL SYNDROME, TYPE 5	0.04	1.996219280455973
SMITH-MAGENIS SYNDROME; SMS	0.04	1.996219280455973
KOOLEN-DE VRIES SYNDROME; KDVS	0.04	1.996219280455973
TRISOMY 12P	0.04	1.996219280455973
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.996219280455973
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	1.996219280455973
KAPUR-TORIELLO SYNDROME	0.04	1.996219280455973
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.996219280455973
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.996219280455973
COCAINE EMBRYOFETOPATHY	0.04	1.996219280455973
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.848349337256197
PEYRONIE DISEASE	0.037037	1.848349337256197
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.848349337256197
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.848349337256197
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.848349337256197
SCIMITAR SYNDROME	0.037037	1.848349337256197
HYPERLYSINEMIA, TYPE I	0.037037	1.848349337256197
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.848349337256197
300270 ADRENOMYODYSTROPHY	0.037037	1.848349337256197
URINARY BLADDER, ATONY OF	0.037037	1.848349337256197
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.848349337256197
GENITOURINARY TRACT ANOMALIES	0.037037	1.848349337256197
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.848349337256197
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.848349337256197
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.848349337256197
NATHALIE SYNDROME	0.037037	1.848349337256197
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.848349337256197
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.848349337256197
GALACTORRHEA	0.037037	1.848349337256197
TESTICULAR TORSION	0.037037	1.848349337256197
ADENOMYOSIS	0.037037	1.848349337256197
DK PHOCOMELIA SYNDROME	0.037037	1.848349337256197
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.035714300000000004	1.7823393561997196
MELORHEOSTOSIS	0.035714300000000004	1.7823393561997196
FIBULAR HEMIMELIA	0.035714300000000004	1.7823393561997196
HENNEKAM-BEEMER SYNDROME	0.035714300000000004	1.7823393561997196
PROTEUS-LIKE SYNDROME	0.035714300000000004	1.7823393561997196
MOSAIC TRISOMY 14	0.035714300000000004	1.7823393561997196
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.035714300000000004	1.7823393561997196
OCULOECTODERMAL SYNDROME; OES	0.035714300000000004	1.7823393561997196
1P36 DELETION SYNDROME	0.035714300000000004	1.7823393561997196
KLIPPEL-TRÉNAUNAY SYNDROME	0.035714300000000004	1.7823393561997196
BECKER NEVUS SYNDROME	0.035714300000000004	1.7823393561997196
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.035714300000000004	1.7823393561997196
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.035714300000000004	1.7823393561997196
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.035714300000000004	1.7823393561997196
TOWNES-BROCKS SYNDROME	0.035714300000000004	1.7823393561997196
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.035714300000000004	1.7823393561997196
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.035714300000000004	1.7823393561997196
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.035714300000000004	1.7823393561997196
DYSSPONDYLOENCHONDROMATOSIS	0.035714300000000004	1.7823393561997196
49,XYYYY SYNDROME	0.035714300000000004	1.7823393561997196
CURRARINO SYNDROME	0.035714300000000004	1.7823393561997196
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.03507117	1.7502436435537279
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.02999326	1.4968280973932233
ALKAPTONURIA	0.029571599999999996	1.4757849518482964
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.02841482	1.41805528836715
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.0284045	1.4175402637927923
ARGININOSUCCINIC ACIDURIA	0.0284045	1.4175402637927923
ARGININOSUCCINIC ACIDURIA	0.0284045	1.4175402637927923
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0284045	1.4175402637927923
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.027407519999999998	1.3677854963370673
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.02522037	1.2586347213558353
CLASSIC MYCOSIS FUNGOIDES	0.02449369	1.2223694056877916
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.024213069999999996	1.2083649293257526
GROWTH HORMONE INSENSITIVITY SYNDROME	0.022539669999999998	1.124853095727877
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.02174815	1.0853519086062144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.02174815	1.0853519086062144
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.02137257	1.0666084076723732
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.02137257	1.0666084076723732
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.02137257	1.0666084076723732
INFANTILE LIVER FAILURE SYNDROME 2	0.02137257	1.0666084076723732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.020740849999999998	1.0350821165761317
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.020740849999999998	1.0350821165761317
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.020740849999999998	1.0350821165761317
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.020740849999999998	1.0350821165761317
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.020740849999999998	1.0350821165761317
FUMARASE DEFICIENCY; FMRD	0.020740849999999998	1.0350821165761317
ADENOCARCINOMA OF OVARY	0.020408199999999998	1.0184810579850399
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.020408199999999998	1.0184810579850399
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.020408199999999998	1.0184810579850399
SYSTEMIC CAPILLARY LEAK SYNDROME	0.020408199999999998	1.0184810579850399
BEHÇET DISEASE	0.020408199999999998	1.0184810579850399
RING CHROMOSOME 22 SYNDROME	0.020408199999999998	1.0184810579850399
CRYPTOCOCCOSIS	0.020408199999999998	1.0184810579850399
NOONAN SYNDROME 8; NS8	0.020408199999999998	1.0184810579850399
INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
HELLP SYNDROME	0.020408199999999998	1.0184810579850399
ERDHEIM-CHESTER DISEASE	0.020408199999999998	1.0184810579850399
POEMS SYNDROME	0.020408199999999998	1.0184810579850399
MULTIPLE MYELOMA	0.020408199999999998	1.0184810579850399
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	1.0184810579850399
NOCARDIOSIS	0.020408199999999998	1.0184810579850399
OVARIAN FIBROMA	0.020408199999999998	1.0184810579850399
OVARIAN FIBROTHECOMA	0.020408199999999998	1.0184810579850399
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020408199999999998	1.0184810579850399
WILD TYPE ATTR AMYLOIDOSIS	0.020408199999999998	1.0184810579850399
WALDENSTRÖM MACROGLOBULINEMIA	0.020408199999999998	1.0184810579850399
HEMORRHAGIC FEVER-RENAL SYNDROME	0.020408199999999998	1.0184810579850399
CHRONIC GRAFT VERSUS HOST DISEASE	0.020408199999999998	1.0184810579850399
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.020408199999999998	1.0184810579850399
PRIMARY SCLEROSING CHOLANGITIS	0.020408199999999998	1.0184810579850399
KIKUCHI-FUJIMOTO DISEASE	0.020408199999999998	1.0184810579850399
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.020408199999999998	1.0184810579850399
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	1.0184810579850399
PANCREATITIS, HEREDITARY	0.020408199999999998	1.0184810579850399
PLEURAL MESOTHELIOMA	0.020408199999999998	1.0184810579850399
LEPTOSPIROSIS	0.020408199999999998	1.0184810579850399
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.020408199999999998	1.0184810579850399
MEIGE DISEASE	0.020408199999999998	1.0184810579850399
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.020408199999999998	1.0184810579850399
AL AMYLOIDOSIS	0.020408199999999998	1.0184810579850399
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.020408199999999998	1.0184810579850399
FOLLICULAR LYMPHOMA	0.020408199999999998	1.0184810579850399
OVARIAN HYPERSTIMULATION SYNDROME	0.020408199999999998	1.0184810579850399
HEMOCHROMATOSIS, TYPE 1	0.020408199999999998	1.0184810579850399
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020408199999999998	1.0184810579850399
MALIGNANT ATROPHIC PAPULOSIS	0.020408199999999998	1.0184810579850399
KAPOSIFORM LYMPHANGIOMATOSIS	0.020408199999999998	1.0184810579850399
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.020408199999999998	1.0184810579850399
LASSA FEVER	0.020408199999999998	1.0184810579850399
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.020408199999999998	1.0184810579850399
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.020365269999999998	1.0163386156422904
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01817812	0.9071878406610584
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.01817812	0.9071878406610584
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.01817812	0.9071878406610584
DENT DISEASE	0.017170819999999996	0.8569180486309758
KNIEST-LIKE DYSPLASIA, LETHAL	0.01702405	0.8495934210361628
CINCA SYNDROME	0.01702405	0.8495934210361628
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.01702405	0.8495934210361628
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.01702405	0.8495934210361628
TOE, ROTATED FIFTH	0.015872999999999998	0.7921497159669414
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.7921497159669414
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.015872999999999998	0.7921497159669414
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.015872999999999998	0.7921497159669414
SCALP-EAR-NIPPLE SYNDROME; SENS	0.015872999999999998	0.7921497159669414
ERYTHROKERATODERMIA VARIABILIS	0.015872999999999998	0.7921497159669414
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.015872999999999998	0.7921497159669414
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.7921497159669414
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.7921497159669414
SILLENCE SYNDROME	0.015872999999999998	0.7921497159669414
LICHEN PLANUS PEMPHIGOIDES	0.015872999999999998	0.7921497159669414
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.015872999999999998	0.7921497159669414
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.015872999999999998	0.7921497159669414
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.7921497159669414
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.015872999999999998	0.7921497159669414
CHILBLAIN LUPUS 1	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.015872999999999998	0.7921497159669414
MONILETHRIX	0.015872999999999998	0.7921497159669414
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.7921497159669414
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.015872999999999998	0.7921497159669414
ADNP SYNDROME	0.015872999999999998	0.7921497159669414
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.7921497159669414
PROGEROID SYNDROME, PETTY TYPE	0.015872999999999998	0.7921497159669414
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.7921497159669414
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.015872999999999998	0.7921497159669414
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.7921497159669414
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.7921497159669414
FUCOSIDOSIS	0.015872999999999998	0.7921497159669414
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.7921497159669414
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.7921497159669414
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.7921497159669414
INTELLECTUAL DISABILITY, WOLFF TYPE	0.015872999999999998	0.7921497159669414
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.7921497159669414
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.7921497159669414
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.015872999999999998	0.7921497159669414
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.7921497159669414
JOHANSON-BLIZZARD SYNDROME; JBS	0.015872999999999998	0.7921497159669414
FLOTCH SYNDROME	0.015872999999999998	0.7921497159669414
ACRODYSOSTOSIS	0.015872999999999998	0.7921497159669414
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.7921497159669414
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.7921497159669414
LUNULAE OF FINGERNAILS	0.015872999999999998	0.7921497159669414
MOEBIUS SYNDROME; MBS	0.015872999999999998	0.7921497159669414
MULTIPLE SYNOSTOSES SYNDROME	0.015872999999999998	0.7921497159669414
ADACTYLIA, UNILATERAL	0.015872999999999998	0.7921497159669414
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.7921497159669414
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.7921497159669414
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.7921497159669414
PILI TORTI	0.015872999999999998	0.7921497159669414
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.7921497159669414
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.7921497159669414
TYROSINEMIA TYPE 2	0.015872999999999998	0.7921497159669414
HEREDITARY METHEMOGLOBINEMIA	0.015872999999999998	0.7921497159669414
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.015872999999999998	0.7921497159669414
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.7921497159669414
DERMATOMYOSITIS	0.015872999999999998	0.7921497159669414
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.01566294	0.781666570415627
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01566294	0.781666570415627
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01544561	0.7708206120100897
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.01528736	0.7629230694817857
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.015070030000000002	0.7520771110762483
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.015070030000000002	0.7520771110762483
COSTELLO SYNDROME; CSTLO	0.015070030000000002	0.7520771110762483
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.014898980000000001	0.7435407783781984
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.014898980000000001	0.7435407783781984
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	0.7435407783781984
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	0.7435407783781984
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	0.7435407783781984
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	0.7435407783781984
CITRULLINEMIA, CLASSIC	0.0147059	0.7339050279114374
SPLENOPORTAL VASCULAR ANOMALIES	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0147059	0.7339050279114374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0147059	0.7339050279114374
PATENT DUCTUS VENOSUS	0.0147059	0.7339050279114374
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0147059	0.7339050279114374
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0147059	0.7339050279114374
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.0147059	0.7339050279114374
GLUTAMINE DEFICIENCY, CONGENITAL	0.0147059	0.7339050279114374
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0147059	0.7339050279114374
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0147059	0.7339050279114374
CITRULLINEMIA TYPE I	0.0147059	0.7339050279114374
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.01370892	0.6841502604557125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.01370892	0.6841502604557125
GLYCOGEN STORAGE DISEASE IB	0.01370892	0.6841502604557125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.01370892	0.6841502604557125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.6841502604557125
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.01370892	0.6841502604557125
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.01370892	0.6841502604557125
PYRUVATE CARBOXYLASE DEFICIENCY	0.01370892	0.6841502604557125
NAVAJO NEUROHEPATOPATHY	0.01370892	0.6841502604557125
HISTIOCYTOID CARDIOMYOPATHY	0.01370892	0.6841502604557125
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.01370892	0.6841502604557125
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.01370892	0.6841502604557125
ISOLATED COMPLEX I DEFICIENCY	0.01370892	0.6841502604557125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.01370892	0.6841502604557125
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.01370892	0.6841502604557125
GLYCOGEN STORAGE DISEASE IA	0.01370892	0.6841502604557125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.013698599999999998	0.6836352358813548
PHENYLKETONURIA	0.013698599999999998	0.6836352358813548
SIALIDOSIS TYPE 1	0.013698599999999998	0.6836352358813548
GALACTOSEMIA	0.013698599999999998	0.6836352358813548
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF	0.013698599999999998	0.6836352358813548
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.013698599999999998	0.6836352358813548
CYSTINOSIS	0.013698599999999998	0.6836352358813548
XERODERMA PIGMENTOSUM	0.013698599999999998	0.6836352358813548
DERMOTRICHIC SYNDROME	0.013698599999999998	0.6836352358813548
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.013698599999999998	0.6836352358813548
NEPHROPATHIC INFANTILE CYSTINOSIS	0.013698599999999998	0.6836352358813548
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.013698599999999998	0.6836352358813548
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
PEELING SKIN SYNDROME	0.013698599999999998	0.6836352358813548
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.013698599999999998	0.6836352358813548
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.013698599999999998	0.6836352358813548
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.013698599999999998	0.6836352358813548
FORMIMINOTRANSFERASE DEFICIENCY	0.013698599999999998	0.6836352358813548
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.013698599999999998	0.6836352358813548
ROWLEY-ROSENBERG SYNDROME	0.013698599999999998	0.6836352358813548
HEREDITARY OROTIC ACIDURIA	0.013698599999999998	0.6836352358813548
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.013698599999999998	0.6836352358813548
STIMMLER SYNDROME	0.013698599999999998	0.6836352358813548
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013698599999999998	0.6836352358813548
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.013698599999999998	0.6836352358813548
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.013698599999999998	0.6836352358813548
LOWE OCULOCEREBRORENAL SYNDROME	0.013698599999999998	0.6836352358813548
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.013698599999999998	0.6836352358813548
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.013698599999999998	0.6836352358813548
OCULOCEREBRORENAL SYNDROME OF LOWE	0.013698599999999998	0.6836352358813548
NETHERTON SYNDROME	0.013698599999999998	0.6836352358813548
DENT DISEASE 1	0.013698599999999998	0.6836352358813548
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.013698599999999998	0.6836352358813548
WILSON DISEASE	0.013698599999999998	0.6836352358813548
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.013698599999999998	0.6836352358813548
GYRATE ATROPHY OF CHOROID AND RETINA	0.013698599999999998	0.6836352358813548
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.01219124	0.608409708516652
ANTISYNTHETASE SYNDROME	0.01209291	0.6035025024704711
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.5545048011768592
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.5545048011768592
PIGMENTED PURPURIC ERUPTION	0.0111111	0.5545048011768592
PILONIDAL SINUS	0.0111111	0.5545048011768592
DERMAL RIDGES, PATTERNLESS	0.0111111	0.5545048011768592
PSEUDOATROPHODERMA COLLI	0.0111111	0.5545048011768592
SAY SYNDROME	0.0111111	0.5545048011768592
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.5545048011768592
AICARDI SYNDROME; AIC	0.0111111	0.5545048011768592
SYRINGOMAS, MULTIPLE	0.0111111	0.5545048011768592
PRENATAL BOWING	0.0111111	0.5545048011768592
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0111111	0.5545048011768592
LATERAL MENINGOCELE SYNDROME	0.0111111	0.5545048011768592
GM1 GANGLIOSIDOSIS	0.0111111	0.5545048011768592
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.5545048011768592
TRIOPIA	0.0111111	0.5545048011768592
CAMOS SYNDROME	0.0111111	0.5545048011768592
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.5545048011768592
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.5545048011768592
CAROTENEMIA, FAMILIAL	0.0111111	0.5545048011768592
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	0.5545048011768592
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.5545048011768592
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.5545048011768592
SHORT SYNDROME	0.0111111	0.5545048011768592
ACROMIAL DIMPLES	0.0111111	0.5545048011768592
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.5545048011768592
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.5545048011768592
131600 EPIDERMOID CYSTS	0.0111111	0.5545048011768592
LENTIGINES	0.0111111	0.5545048011768592
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.5545048011768592
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.5545048011768592
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.5545048011768592
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.5545048011768592
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.5545048011768592
FUTCHER LINE	0.0111111	0.5545048011768592
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.5545048011768592
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.5545048011768592
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.5545048011768592
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.5545048011768592
KYRLE DISEASE	0.0111111	0.5545048011768592
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.5545048011768592
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.5545048011768592
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.5545048011768592
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.5545048011768592
LICHEN PLANUS, FAMILIAL	0.0111111	0.5545048011768592
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.5545048011768592
PARANA HARD-SKIN SYNDROME	0.0111111	0.5545048011768592
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.5545048011768592
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	0.5545048011768592
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0111111	0.5545048011768592
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.5545048011768592
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	0.5545048011768592
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.0111111	0.5545048011768592
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.5545048011768592
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.5545048011768592
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.5545048011768592
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.5545048011768592
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.5545048011768592
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.5545048011768592
PYCNODYSOSTOSIS	0.0111111	0.5545048011768592
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.5545048011768592
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	0.5545048011768592
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.5545048011768592
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.5545048011768592
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0111111	0.5545048011768592
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.5545048011768592
CURRY-JONES SYNDROME	0.0111111	0.5545048011768592
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0111111	0.5545048011768592
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.5545048011768592
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.5545048011768592
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.5545048011768592
TRICHILEMMAL CYST 1	0.0111111	0.5545048011768592
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.01051447	0.5247296934443979
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01051447	0.5247296934443979
MELAS	0.01051447	0.5247296934443979
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.01051447	0.5247296934443979
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.01051447	0.5247296934443979
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.01051447	0.5247296934443979
CADASIL	0.010138890000000001	0.5059861925105567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010138890000000001	0.5059861925105567
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.4302196897208501
KAWASAKI DISEASE	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.4302196897208501
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00862069	0.4302196897208501
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00862069	0.4302196897208501
DUODENAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
JEJUNAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
CREST SYNDROME	0.00862069	0.4302196897208501
ILEAL NEUROENDOCRINE TUMOR	0.00862069	0.4302196897208501
JOHANSON-BLIZZARD SYNDROME	0.00862069	0.4302196897208501
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.00862069	0.4302196897208501
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.4302196897208501
LETHAL KNIEST-LIKE DYSPLASIA	0.00862069	0.4302196897208501
BAZEX SYNDROME	0.00862069	0.4302196897208501
NK-CELL ENTEROPATHY	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00862069	0.4302196897208501
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.4302196897208501
RETINAL VENOUS BEADING	0.00862069	0.4302196897208501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00862069	0.4302196897208501
GLYCOGEN STORAGE DISEASE IV	0.00862069	0.4302196897208501
PORPHYRIA CUTANEA TARDA	0.00862069	0.4302196897208501
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.4302196897208501
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.4302196897208501
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.4302196897208501
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.4302196897208501
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.4302196897208501
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00862069	0.4302196897208501
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.4302196897208501
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00862069	0.4302196897208501
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00862069	0.4302196897208501
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00862069	0.4302196897208501
%152800 LYMPHANGIECTASIA, INTESTINAL	0.00862069	0.4302196897208501
RETINITIS PIGMENTOSA 71; RP71	0.00862069	0.4302196897208501
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.4302196897208501
OPSISMODYSPLASIA; OPSMD	0.00862069	0.4302196897208501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00862069	0.4302196897208501
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.00862069	0.4302196897208501
CHÉDIAK-HIGASHI SYNDROME	0.00862069	0.4302196897208501
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.4302196897208501
PEHO-LIKE SYNDROME; PEHOL	0.00862069	0.4302196897208501
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00862069	0.4302196897208501
PRADER-WILLI SYNDROME	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00862069	0.4302196897208501
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.4302196897208501
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00862069	0.4302196897208501
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.4302196897208501
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00862069	0.4302196897208501
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.4302196897208501
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.4302196897208501
WELLS SYNDROME	0.00862069	0.4302196897208501
SYSTEMIC SCLEROSIS	0.00862069	0.4302196897208501
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.4302196897208501
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.4302196897208501
NOONAN SYNDROME 6; NS6	0.00862069	0.4302196897208501
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.4302196897208501
SAPHO SYNDROME	0.00862069	0.4302196897208501
PLAGUE	0.00862069	0.4302196897208501
ENHANCED S-CONE SYNDROME	0.00862069	0.4302196897208501
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00862069	0.4302196897208501
PIERSON SYNDROME	0.00862069	0.4302196897208501
PAPILLORENAL SYNDROME	0.00862069	0.4302196897208501
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.4302196897208501
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00862069	0.4302196897208501
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.4302196897208501
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.4302196897208501
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00862069	0.4302196897208501
SEA-BLUE HISTIOCYTOSIS	0.00862069	0.4302196897208501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00862069	0.4302196897208501
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.4302196897208501
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.4302196897208501
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.4302196897208501
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00862069	0.4302196897208501
DERMATITIS HERPETIFORMIS	0.00862069	0.4302196897208501
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.4302196897208501
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.4302196897208501
MAJEED SYNDROME	0.00862069	0.4302196897208501
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.4302196897208501
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.4302196897208501
PREECLAMPSIA/ECLAMPSIA 1	0.00862069	0.4302196897208501
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.4302196897208501
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.4302196897208501
THORACIC OUTLET SYNDROME	0.00862069	0.4302196897208501
LIPEDEMA	0.00862069	0.4302196897208501
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.4302196897208501
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00862069	0.4302196897208501
OMENN SYNDROME	0.00862069	0.4302196897208501
DISTAL MONOSOMY 17Q	0.00840336	0.4193737313153127
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00840336	0.4193737313153127
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.4193737313153127
GALLOWAY-MOWAT SYNDROME	0.00840336	0.4193737313153127
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.4193737313153127
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00840336	0.4193737313153127
EMANUEL SYNDROME	0.00840336	0.4193737313153127
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.4193737313153127
GMS SYNDROME	0.00840336	0.4193737313153127
FG SYNDROME TYPE 1	0.00840336	0.4193737313153127
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.4193737313153127
INFANTILE SIALIC ACID STORAGE DISEASE	0.00840336	0.4193737313153127
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.4193737313153127
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.4193737313153127
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.4193737313153127
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.4193737313153127
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.4193737313153127
ROBERTS SYNDROME	0.00840336	0.4193737313153127
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00840336	0.4193737313153127
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.4193737313153127
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.4193737313153127
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00840336	0.4193737313153127
RENAL TUBULAR DYSGENESIS	0.00840336	0.4193737313153127
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.4193737313153127
ADAMS-OLIVER SYNDROME	0.00840336	0.4193737313153127
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.4193737313153127
EBSTEIN MALFORMATION	0.00840336	0.4193737313153127
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.4193737313153127
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.4193737313153127
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.4193737313153127
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.4193737313153127
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.4193737313153127
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.4193737313153127
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.4193737313153127
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.4193737313153127
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.4193737313153127
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.4193737313153127
CORNELIA DE LANGE SYNDROME	0.00840336	0.4193737313153127
CARDIOFACIOCUTANEOUS SYNDROME	0.00840336	0.4193737313153127
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00840336	0.4193737313153127
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.4193737313153127
DISTAL MONOSOMY 10Q	0.00840336	0.4193737313153127
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.4193737313153127
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.4193737313153127
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00840336	0.4193737313153127
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.4193737313153127
FATCO SYNDROME	0.00840336	0.4193737313153127
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.4193737313153127
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.4193737313153127
CONGENITAL TOXOPLASMOSIS	0.00840336	0.4193737313153127
CONGENITAL ANALBUMINEMIA	0.00840336	0.4193737313153127
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.4193737313153127
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.4193737313153127
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.4193737313153127
PEMPHIGOID GESTATIONIS	0.00840336	0.4193737313153127
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.4193737313153127
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.4193737313153127
SCHISIS ASSOCIATION	0.00840336	0.4193737313153127
NEMALINE MYOPATHY 10	0.00840336	0.4193737313153127
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.4193737313153127
VACTERL/VATER ASSOCIATION	0.00840336	0.4193737313153127
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.4193737313153127
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.4193737313153127
RETINOPATHY OF PREMATURITY	0.00840336	0.4193737313153127
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.4193737313153127
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.4193737313153127
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.4193737313153127
HEC SYNDROME	0.00840336	0.4193737313153127
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.4193737313153127
JACOBSEN SYNDROME	0.00840336	0.4193737313153127
TYSHCHENKO SYNDROME	0.00840336	0.4193737313153127
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.4193737313153127
KAGAMI-OGATA SYNDROME	0.00840336	0.4193737313153127
TEMPLE SYNDROME	0.00840336	0.4193737313153127
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.4193737313153127
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.4193737313153127
ROIFMAN SYNDROME; RFMN	0.00840336	0.4193737313153127
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.4193737313153127
GAUCHER DISEASE, PERINATAL LETHAL	0.00840336	0.4193737313153127
YUNIS-VARON SYNDROME	0.00840336	0.4193737313153127
OMPHALOCELE	0.00840336	0.4193737313153127
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00840336	0.4193737313153127
KAGAMI-OGATA SYNDROME	0.00840336	0.4193737313153127
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00840336	0.4193737313153127
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.4193737313153127
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.4193737313153127
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.4193737313153127
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00840336	0.4193737313153127
HYDROLETHALUS	0.00840336	0.4193737313153127
TEMPLE SYNDROME	0.00840336	0.4193737313153127
ZELLWEGER SYNDROME	0.00840336	0.4193737313153127
MYOPATHY, SPHEROID BODY	0.0072601	0.3623187899509603
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00704225	0.3514468806947769
KEARNS-SAYRE SYNDROME; KSS	0.00704225	0.3514468806947769
GRACILE SYNDROME	0.00704225	0.3514468806947769
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00704225	0.3514468806947769
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00704225	0.3514468806947769
SUCCINIC ACIDEMIA	0.00704225	0.3514468806947769
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.3514468806947769
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.00704225	0.3514468806947769
LIVER FAILURE, INFANTILE, TRANSIENT	0.00704225	0.3514468806947769
PEARSON SYNDROME	0.00704225	0.3514468806947769
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00704225	0.3514468806947769
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00704225	0.3514468806947769
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.3514468806947769
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.3514468806947769
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00704225	0.3514468806947769
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00704225	0.3514468806947769
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.00704225	0.3514468806947769
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00704225	0.3514468806947769
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00704225	0.3514468806947769
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.3514468806947769
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.3514468806947769
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00704225	0.3514468806947769
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00704225	0.3514468806947769
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.3514468806947769
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00704225	0.3514468806947769
3-HYDROXYISOBUTYRIC ACIDURIA	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00704225	0.3514468806947769
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.3514468806947769
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00704225	0.3514468806947769
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00704225	0.3514468806947769
LEIGH SYNDROME; LS	0.00704225	0.3514468806947769
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.3514468806947769
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00704225	0.3514468806947769
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00704225	0.3514468806947769
PSEUDO-TORCH SYNDROME 2	0.00704225	0.3514468806947769
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00704225	0.3514468806947769
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.3514468806947769
INFANTILE LIVER FAILURE SYNDROME 1	0.00704225	0.3514468806947769
COLCHICINE POISONING	0.00704225	0.3514468806947769
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00704225	0.3514468806947769
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00704225	0.3514468806947769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00704225	0.3514468806947769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00704225	0.3514468806947769
SHEEHAN SYNDROME	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	0.33270337976093556
MPI-CDG	0.00666667	0.33270337976093556
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.33270337976093556
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.33270337976093556
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00666667	0.33270337976093556
ENDOCARDIAL FIBROELASTOSIS	0.00666667	0.33270337976093556
MENKES DISEASE	0.00666667	0.33270337976093556
HOLOPROSENCEPHALY	0.00666667	0.33270337976093556
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.33270337976093556
OCULODENTODIGITAL DYSPLASIA	0.00666667	0.33270337976093556
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	0.33270337976093556
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	0.33270337976093556
LEPRECHAUNISM	0.00666667	0.33270337976093556
PITUITARY STALK INTERRUPTION SYNDROME	0.00666667	0.33270337976093556
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.33270337976093556
COG8-CDG	0.00666667	0.33270337976093556
NEONATAL HEMOCHROMATOSIS	0.00666667	0.33270337976093556
PITUITARY APOPLEXY	0.00666667	0.33270337976093556
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00666667	0.33270337976093556
ACUTE ADRENAL INSUFFICIENCY	0.00666667	0.33270337976093556
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.33270337976093556
CLASSIC GALACTOSEMIA	0.00666667	0.33270337976093556
HEPATOCELLULAR CARCINOMA	0.00666667	0.33270337976093556
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.33270337976093556
PANHYPOPITUITARISM	0.00666667	0.33270337976093556
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.00666667	0.33270337976093556
LARON SYNDROME	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.33270337976093556
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	0.33270337976093556
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	0.33270337976093556
ADDISON DISEASE	0.00666667	0.33270337976093556
GALACTOSEMIA	0.00666667	0.33270337976093556
SOTOS SYNDROME	0.00666667	0.33270337976093556
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.33270337976093556
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.00666667	0.33270337976093556
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.33270337976093556
MIRAGE SYNDROME; MIRAGE	0.00666667	0.33270337976093556
TIMOTHY SYNDROME; TS	0.00666667	0.33270337976093556
SMITH-KINGSMORE SYNDROME; SKS	0.00666667	0.33270337976093556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00666667	0.33270337976093556
TENORIO SYNDROME; TNORS	0.00666667	0.33270337976093556
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.33270337976093556
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	0.33270337976093556
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.33270337976093556
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.33270337976093556
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.33270337976093556
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.33270337976093556
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.33270337976093556
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00666667	0.33270337976093556
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	0.33270337976093556
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	0.33270337976093556
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.33270337976093556
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00666667	0.33270337976093556
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	0.33270337976093556
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.33270337976093556
GLYCOGEN STORAGE DISEASE VI	0.00666667	0.33270337976093556
HOLOPROSENCEPHALY 1; HPE1	0.00666667	0.33270337976093556
HYPOADRENOCORTICISM, FAMILIAL	0.00666667	0.33270337976093556
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	0.33270337976093556
SHASHI-PENA SYNDROME; SHAPNS	0.00666667	0.33270337976093556
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	0.33270337976093556
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.33270337976093556
CONGENITAL DISORDER OF GLYCOSYLATION	0.00666667	0.33270337976093556
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.33270337976093556
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00666667	0.33270337976093556
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	0.33270337976093556
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00666667	0.33270337976093556
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.33270337976093556
MEHMO SYNDROME; MEHMO	0.00666667	0.33270337976093556
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.33270337976093556
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	0.1890359772013393
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1890359772013393
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1890359772013393
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1890359772013393
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1890359772013393
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.00378788	0.1890359772013393
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	0.1890359772013393
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1890359772013393
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1890359772013393
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1890359772013393
CALVARIAL HYPEROSTOSIS	0.00378788	0.1890359772013393
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1890359772013393
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1890359772013393
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1890359772013393
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1890359772013393
NEPHROSIALIDOSIS	0.00378788	0.1890359772013393
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.1890359772013393
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1890359772013393
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1890359772013393
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	0.1890359772013393
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1890359772013393
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1890359772013393
LYMPHOKINE DEFICIENCY	0.00378788	0.1890359772013393
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1890359772013393
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.1890359772013393
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.1890359772013393
GRANULOMAS, CONGENITAL CEREBRAL	0.00378788	0.1890359772013393
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1890359772013393
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.1890359772013393
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1890359772013393
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1890359772013393
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1890359772013393
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1890359772013393
FINGERPRINT BODY MYOPATHY	0.00378788	0.1890359772013393
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1890359772013393
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1890359772013393
OSTEOGENIC SARCOMA	0.00378788	0.1890359772013393
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1890359772013393
LARON SYNDROME	0.00378788	0.1890359772013393
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.1890359772013393
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1890359772013393
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1890359772013393
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1890359772013393
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.1890359772013393
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1890359772013393
XYLOSIDASE DEFICIENCY	0.00378788	0.1890359772013393
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1890359772013393
XANTHINURIA, TYPE I	0.00378788	0.1890359772013393
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1890359772013393
PITUITARY DWARFISM IV	0.00378788	0.1890359772013393
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1890359772013393
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1890359772013393
PENDRED SYNDROME	0.00378788	0.1890359772013393
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1890359772013393
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1890359772013393
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1890359772013393
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.1890359772013393
T-SUBSTANCE ANOMALY	0.00378788	0.1890359772013393
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1890359772013393
REVESZ SYNDROME	0.00378788	0.1890359772013393
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	0.1890359772013393
PYGMY	0.00378788	0.1890359772013393
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.1890359772013393
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1890359772013393
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00378788	0.1890359772013393
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1890359772013393
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1890359772013393
NEONATAL ADRENOLEUKODYSTROPHY	0.00378788	0.1890359772013393
PROGESTERONE RESISTANCE	0.00378788	0.1890359772013393
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1890359772013393
ALAND ISLAND EYE DISEASE	0.00378788	0.1890359772013393
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1890359772013393
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.1890359772013393
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1890359772013393
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1890359772013393
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1890359772013393
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.1890359772013393
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	0.1890359772013393
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	0.1890359772013393
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1890359772013393
GLUTATHIONURIA	0.00378788	0.1890359772013393
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1890359772013393
PACMAN DYSPLASIA	0.00378788	0.1890359772013393
PERRY SYNDROME	0.00378788	0.1890359772013393
PARAOXONASE 1	0.00378788	0.1890359772013393
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1890359772013393
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1890359772013393
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1890359772013393
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1890359772013393
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1890359772013393
SPINAL ARACHNOIDITIS	0.00378788	0.1890359772013393
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1890359772013393
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1890359772013393
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1890359772013393
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.1890359772013393
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1890359772013393
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1890359772013393
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1890359772013393
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1890359772013393
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1890359772013393
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1890359772013393
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.1890359772013393
OVARIAN CANCER	0.00378788	0.1890359772013393
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.1890359772013393
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1890359772013393
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1890359772013393
BEETURIA	0.00378788	0.1890359772013393
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.1890359772013393
CARBOXYLESTERASE 1	0.00378788	0.1890359772013393
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1890359772013393
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1890359772013393
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1890359772013393
COUMARIN RESISTANCE	0.00378788	0.1890359772013393
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1890359772013393
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1890359772013393
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1890359772013393
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1890359772013393
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1890359772013393
FLOOD FACTOR DEFICIENCY	0.00378788	0.1890359772013393
GLUTATHIONE REDUCTASE	0.00378788	0.1890359772013393
HEINZ BODY ANEMIAS	0.00378788	0.1890359772013393
HYPERPROGLUCAGONEMIA	0.00378788	0.1890359772013393
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1890359772013393
APOLIPOPROTEIN(A)	0.00378788	0.1890359772013393
ZINC, ELEVATED PLASMA	0.00378788	0.1890359772013393
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1890359772013393
ACETYLATION, SLOW	0.00378788	0.1890359772013393
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	0.1890359772013393
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.1890359772013393
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	0.1890359772013393
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1890359772013393
EPILEPSY-TELANGIECTASIA	0.00378788	0.1890359772013393
REFSUM DISEASE	0.00378788	0.1890359772013393
ETHANOLAMINOSIS	0.00378788	0.1890359772013393
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1890359772013393
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1890359772013393
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1890359772013393
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1890359772013393
GAPO SYNDROME; GAPOS	0.00378788	0.1890359772013393
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.1890359772013393
HOOFT DISEASE	0.00378788	0.1890359772013393
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.1890359772013393
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1890359772013393
HYPOASCORBEMIA	0.00378788	0.1890359772013393
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.1890359772013393
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00378788	0.1890359772013393
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00378788	0.1890359772013393
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.1890359772013393
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1890359772013393
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1890359772013393
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1890359772013393
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1890359772013393
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1890359772013393
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.1890359772013393
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1890359772013393
AREDYLD	0.00378788	0.1890359772013393
ASPARTYLGLUCOSAMINURIA; AGU	0.00378788	0.1890359772013393
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.1890359772013393
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.1890359772013393
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1890359772013393
CEPHALIN LIPIDOSIS	0.00378788	0.1890359772013393
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.1890359772013393
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.00378788	0.1890359772013393
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.1890359772013393
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1890359772013393
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1890359772013393
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1890359772013393
DERMATOLEUKODYSTROPHY	0.00378788	0.1890359772013393
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1890359772013393
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1890359772013393
ICHTHYOSIS, X-LINKED	0.00378788	0.1890359772013393
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1890359772013393
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1890359772013393
CUTIS LAXA	0.00378788	0.1890359772013393
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00378788	0.1890359772013393
SALLA DISEASE	0.00378788	0.1890359772013393
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00378788	0.1890359772013393
DERMATITIS, ATOPIC	0.00378788	0.1890359772013393
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	0.1890359772013393
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1890359772013393
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1890359772013393
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1890359772013393
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.1890359772013393
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1890359772013393
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	0.1890359772013393
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1890359772013393
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1890359772013393
SCHIZOPHRENIA 4	0.00378788	0.1890359772013393
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1890359772013393
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.1890359772013393
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1890359772013393
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1890359772013393
LARSEN-LIKE SYNDROME	0.00378788	0.1890359772013393
46,XX GONADAL DYSGENESIS	0.00378788	0.1890359772013393
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1890359772013393
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1890359772013393
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1890359772013393
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1890359772013393
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1890359772013393
CHROMOSOME 10Q26 DELETION SYNDROME	0.00378788	0.1890359772013393
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.1890359772013393
NEURONAL CEROID LIPOFUSCINOSIS	0.00378788	0.1890359772013393
EMANUEL SYNDROME	0.00378788	0.1890359772013393
OSTEOMESOPYKNOSIS	0.00378788	0.1890359772013393
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1890359772013393
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.1890359772013393
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1890359772013393
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.1890359772013393
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.1890359772013393
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.1890359772013393
XM SYSTEM	0.00378788	0.1890359772013393
GONADOBLASTOMA	0.00378788	0.1890359772013393
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1890359772013393
ONCOCYTOMA	0.00378788	0.1890359772013393
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1890359772013393
MACROCYTOSIS, FAMILIAL	0.00378788	0.1890359772013393
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	0.1890359772013393
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1890359772013393
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1890359772013393
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.1890359772013393
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1890359772013393
BARTTER SYNDROME	0.00378788	0.1890359772013393
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1890359772013393
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.00378788	0.1890359772013393
DELETED IN AZOOSPERMIA	0.00378788	0.1890359772013393
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00347222	0.17328281274962098
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00347222	0.17328281274962098
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00347222	0.17328281274962098
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00347222	0.17328281274962098
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00347222	0.17328281274962098
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00347222	0.17328281274962098
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00347222	0.17328281274962098
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.00347222	0.17328281274962098
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00347222	0.17328281274962098
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00347222	0.17328281274962098
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00347222	0.17328281274962098
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00347222	0.17328281274962098
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00347222	0.17328281274962098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00347222	0.17328281274962098
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00347222	0.17328281274962098
MYOTONIA FLUCTUANS	0.00347222	0.17328281274962098
BETHLEM MYOPATHY 2; BTHLM2	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00347222	0.17328281274962098
CRAMPS, FAMILIAL ADOLESCENT	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00347222	0.17328281274962098
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00347222	0.17328281274962098
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00347222	0.17328281274962098
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	0.00347222	0.17328281274962098
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00347222	0.17328281274962098
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00347222	0.17328281274962098
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00347222	0.17328281274962098
CHOREOACANTHOCYTOSIS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00347222	0.17328281274962098
AXIAL OSTEOMALACIA	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00347222	0.17328281274962098
SCHWARTZ-JAMPEL SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00347222	0.17328281274962098
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.00347222	0.17328281274962098
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00347222	0.17328281274962098
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00347222	0.17328281274962098
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00347222	0.17328281274962098
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, INFANTILE-ONSET	0.00347222	0.17328281274962098
EPISODIC ATAXIA, TYPE 1; EA1	0.00347222	0.17328281274962098
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00347222	0.17328281274962098
BETHLEM MYOPATHY 1	0.00347222	0.17328281274962098
JUVENILE DERMATOMYOSITIS	0.00347222	0.17328281274962098
MUSCLE CRAMPS, FAMILIAL	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.00347222	0.17328281274962098
NEUROLEPTIC MALIGNANT SYNDROME	0.00347222	0.17328281274962098
LISSENCEPHALY 8; LIS8	0.00347222	0.17328281274962098
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00347222	0.17328281274962098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00347222	0.17328281274962098
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00347222	0.17328281274962098
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00347222	0.17328281274962098
ZEBRA BODY MYOPATHY	0.00347222	0.17328281274962098
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.00347222	0.17328281274962098
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00347222	0.17328281274962098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00347222	0.17328281274962098
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00347222	0.17328281274962098
DISTAL MYOTILINOPATHY	0.00347222	0.17328281274962098
STORMORKEN SYNDROME; STRMK	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00347222	0.17328281274962098
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00347222	0.17328281274962098
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00347222	0.17328281274962098
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00347222	0.17328281274962098
WILLIAMS SYNDROME	0.00347222	0.17328281274962098
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.00347222	0.17328281274962098
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00347222	0.17328281274962098
DUCHENNE MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00347222	0.17328281274962098
BECKER MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00347222	0.17328281274962098
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00347222	0.17328281274962098
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00347222	0.17328281274962098
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00347222	0.17328281274962098
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00347222	0.17328281274962098
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00347222	0.17328281274962098
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00347222	0.17328281274962098
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00347222	0.17328281274962098
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00347222	0.17328281274962098
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00347222	0.17328281274962098
DYSTROPHIA MYOTONICA 2	0.00347222	0.17328281274962098
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00347222	0.17328281274962098
XQ12-Q13.3 DUPLICATION SYNDROME	0.00347222	0.17328281274962098
NONAKA MYOPATHY	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00347222	0.17328281274962098
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00347222	0.17328281274962098
RIPPLING MUSCLE DISEASE; RMD	0.00347222	0.17328281274962098
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00347222	0.17328281274962098
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00347222	0.17328281274962098
MYOTONIA, POTASSIUM-AGGRAVATED	0.00347222	0.17328281274962098
FOCAL MYOSITIS	0.00347222	0.17328281274962098
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00347222	0.17328281274962098
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00347222	0.17328281274962098
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00347222	0.17328281274962098
COWCHOCK SYNDROME; COWCK	0.00347222	0.17328281274962098
TETANUS	0.00347222	0.17328281274962098
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00347222	0.17328281274962098
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00347222	0.17328281274962098
MCLEOD SYNDROME; MCLDS	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00347222	0.17328281274962098
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00347222	0.17328281274962098
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00347222	0.17328281274962098
MUSCLE GLYCOGENOSIS, X-LINKED	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.00347222	0.17328281274962098
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00347222	0.17328281274962098
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00347222	0.17328281274962098
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00347222	0.17328281274962098
TYPICAL NEMALINE MYOPATHY	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00347222	0.17328281274962098
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00347222	0.17328281274962098
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00347222	0.17328281274962098
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.00347222	0.17328281274962098
SALIH MYOPATHY; SALMY	0.00347222	0.17328281274962098
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00347222	0.17328281274962098
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00347222	0.17328281274962098
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00347222	0.17328281274962098
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00347222	0.17328281274962098
HYPERKALEMIC PERIODIC PARALYSIS	0.00347222	0.17328281274962098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.00347222	0.17328281274962098
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE V; GSD5	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE II	0.00347222	0.17328281274962098
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00347222	0.17328281274962098
POLYMYOSITIS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00347222	0.17328281274962098
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00347222	0.17328281274962098
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00347222	0.17328281274962098
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00347222	0.17328281274962098
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00347222	0.17328281274962098
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.00347222	0.17328281274962098
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00347222	0.17328281274962098
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.00347222	0.17328281274962098
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00347222	0.17328281274962098
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00347222	0.17328281274962098
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.00347222	0.17328281274962098
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00347222	0.17328281274962098
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00347222	0.17328281274962098
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00347222	0.17328281274962098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00347222	0.17328281274962098
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00347222	0.17328281274962098
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00347222	0.17328281274962098
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00347222	0.17328281274962098
MUSCLE-EYE-BRAIN DISEASE	0.00347222	0.17328281274962098
CENTRAL CORE DISEASE	0.00347222	0.17328281274962098
MYOTILINOPATHY	0.00347222	0.17328281274962098
INCLUSION BODY MYOSITIS	0.00347222	0.17328281274962098
POTASSIUM-AGGRAVATED MYOTONIA	0.00347222	0.17328281274962098
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.00347222	0.17328281274962098
FACIOSCAPULOHUMERAL DYSTROPHY	0.00347222	0.17328281274962098
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.00347222	0.17328281274962098
MARINESCO-SJOGREN SYNDROME; MSS	0.00347222	0.17328281274962098
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00347222	0.17328281274962098
